Progress toward prevention of cardiovascular disease. A 30-year retrospective.
Since its creation as the National Heart Institute in 1948, the National Heart, Lung, and Blood Institute (NHLBI) has led a national biomedical research program in heart, lung, blood, and blood vessel diseases, and has become increasingly involved in complex clinical trials to validate its research findings. In addition, NHLBI sponsors demonstrations and educational activities to apply proved research findings in the health care community. NHLBI's approach to these responsibilities involves acquiring new and basic information, testing and evaluating the information, and applying it to improve prevention, detection, and treatment of disease. New equipment such as the heart-lung machine and the pacemaker, better diagnostic procedures, new operative and treatment devices, new drugs, and increased use of preventive medicine have dramatically reduced mortality from heart attack, hypertension and stroke.
D000047:Academies and Institutes; D000572:American Heart Association; D000846:Anniversaries and Special Events; D002318:Cardiovascular Diseases / Q000266:history / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D049673:History, 20th Century; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000266:history*; D014481:United States